文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 基础医学 > In vitro target validation and in vivo efficacy of p38 MAP kinase inhibition in established chronic
侵权投诉

In vitro target validation and in vivo efficacy of p38 MAP kinase inhibition in established chronic

In vitro target validation and in vivo efficacy of p38 MAP kinase inhibition in established chronic collagen-induced arthritis model a pre-clinical study

In vitro target validation and in vivo ef cacy of p38 MAP kinase inhibition in established chronic collagen-induced

arthritis model: a pre-clinical study

K. Triantaphyllopoulos1,2, L. Madden1, I. Rioja3, D. Essex1, J. Buckton3,

R. Malhotra3, K. Ray3, M. Binks3, E.M. Paleolog1

Kennedy Institute of Rheumatology, and 2Faculty of Medicine, National Heart and Lung Institute, Imperial College London, United Kingdom; 3GSK Medicines Research Centre, Stevenage, United Kingdom.

1

Objective

The aim of the present study was to determine the in vivo ef cacy of p38 mitogen-activated protein kinase (MAPK)

inhibitors, namely GW856553X and GSK678361, in murine models of arthritis.Methods

The effect of p38 MAPK inhibitors was tested in 2 variants of the collagen-induced arthritis model (CIA) in DBA/1 mice, acute arthritis induced by heterologous collagen and chronic relapsing arthritis induced by homologous collagen. Animals were treated after onset of arthritis. Furthermore, post-onset disease ef cacy of GSK678361 was tested in the chronic model, so as to determine the effects on established arthritis. In vitro studies were carried out with GW856553X, using

human umbilical vein endothelial cells, to determine potential effects of GW856553X on the vasculature.

Results

In both acute and chronic arthritis, GW856553X reduced signs and symptoms of disease, and protected joints from damage. The effect of GW856553X in chronic CIA was con rmed using an alternative compound, GSK678361. Importantly, treatment with GSK678361 from 14 days post-onset of chronic arthritis completely reversed signs of established disease and joint destruction. Mechanism of action studies demonstrated that GW856553X inhibited endothelial cell migration and angiogenesis in vitro, with reduced pro-in ammatory cytokine production.Conclusions

Suppression of murine CIA by the p38 MAPK inhibitors GW856553X and GSK678361 suggests that they may have

therapeutic potential for future use in RA if safe clinical dosing achieves adequate compound exposure.

Key words

Arthritis, mouse, p38 MAP kinase, cytokine, joint.

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email